Rw. Townsend et al., Biodistribution of 4-[C-14]cholesterol-ambisome following a single intravenous administration to rats, DRUG META D, 29(5), 2001, pp. 681-685
A biodistribution study of 4-[C-14] cholesterol-AmBisome; a unilamellar lip
osomal preparation of amphotericin B was conducted to support a radiolabele
d human study. The radioactive plasma concentration profile (as measured in
mug-Eq/ml of cholesterol) was best fit to a sum of three exponentials that
yielded alpha-, beta-, and gamma -half-life estimates of 3.0 +/- 0.3, 11.8
+/- 3.7, and 113.4 +/- 32.4 h, respectively. Clearance and the steady stat
e volume of distribution were 4.9 +/- 0.2 ml/h/kg and 341 ml/kg. Recovery d
ata collected up through 96 h demonstrated mass balance and indicated that
although the elimination profile in both urine and feces were incomplete, t
he dominant route of elimination (< 2% in urine versus 33% in feces) was fe
ces, presumably via biliary excretion of intact liposome and/or cholesterol
. The liver, spleen, and lungs, organs of the reticuloendothelial system kn
own for their rapid uptake of liposomes, presented with the highest levels
of radioactivity. Levels in the kidney were 15% of that found in the liver
and lungs.